ClinVar Miner

Submissions for variant NM_001042492.3(NF1):c.847G>T (p.Asp283Tyr)

gnomAD frequency: 0.00002  dbSNP: rs200572531
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000205213 SCV000261381 uncertain significance Neurofibromatosis, type 1 2024-01-18 criteria provided, single submitter clinical testing This sequence change replaces aspartic acid, which is acidic and polar, with tyrosine, which is neutral and polar, at codon 283 of the NF1 protein (p.Asp283Tyr). This variant is present in population databases (rs200572531, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with NF1-related conditions. ClinVar contains an entry for this variant (Variation ID: 41680). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on NF1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago RCV001027794 SCV001190404 uncertain significance Neurofibromatosis, familial spinal; Neurofibromatosis, type 1; Neurofibromatosis-Noonan syndrome; Café-au-lait macules with pulmonary stenosis 2019-07-15 criteria provided, single submitter clinical testing NF1 NM_000267.3 exon 8 p.Asp283Tyr (c.847G>T): This variant has not been reported in the literature and is present in 0.006% (1/16242) of African alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/17-29509642-G-T). This variant is present in ClinVar (Variation ID:41680). Evolutionary conservation and computational predictive tools suggest that this variant may impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain.
Genome-Nilou Lab RCV000205213 SCV002561834 uncertain significance Neurofibromatosis, type 1 2022-03-15 criteria provided, single submitter clinical testing
GeneDx RCV000034592 SCV002577273 uncertain significance not provided 2022-09-29 criteria provided, single submitter clinical testing In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 22703879)
Ambry Genetics RCV003764658 SCV002681595 likely benign Cardiovascular phenotype 2020-12-07 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: observed in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Fulgent Genetics, Fulgent Genetics RCV002490460 SCV002784445 uncertain significance Neurofibromatosis, familial spinal; Juvenile myelomonocytic leukemia; Neurofibromatosis, type 1; Neurofibromatosis-Noonan syndrome; Café-au-lait macules with pulmonary stenosis 2021-12-07 criteria provided, single submitter clinical testing
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago RCV002490460 SCV003920274 uncertain significance Neurofibromatosis, familial spinal; Juvenile myelomonocytic leukemia; Neurofibromatosis, type 1; Neurofibromatosis-Noonan syndrome; Café-au-lait macules with pulmonary stenosis 2021-03-30 criteria provided, single submitter clinical testing NF1 NM_000267.3 exon 8 p.Asp283Tyr (c.847G>T): This variant has not been reported in the literature and is present in 0.006% (1/16242) of African alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/17-29509642-G-T). This variant is present in ClinVar (Variation ID:41680). Evolutionary conservation and computational predictive tools suggest that this variant may impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain.
Biesecker Lab/Clinical Genomics Section, National Institutes of Health RCV000034592 SCV000043385 variant of unknown significance not provided 2012-07-13 no assertion criteria provided research Converted during submission to Uncertain significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.